Zobrazeno 1 - 10
of 28
pro vyhledávání: '"OLGA DELGADO-SANCHEZ"'
Autor:
Miguel G. Uriol-Rivera, Aina Obrador-Mulet, Maria Rosa Juliá, Vanessa Daza-Cajigal, Olga Delgado-Sanchez, Angel Garcia Alvarez, Ana Gomez-Lobon, Paula Carrillo-Garcia, Carlos Saus-Sarrias, Cristina Gómez-Cobo, Daniel Ramis-Cabrer, Joan Gasco Company, Javier Molina-Infante, The Balear IgA Research and Treatment Project
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract There is no established treatment for progressive IgA nephropathy refractory to steroids and immunosuppressant drugs (r-IgAN). Interleukin 17 (IL-17) blockade has garnered interest in immune-mediated diseases involving the gut-kidney axis. H
Externí odkaz:
https://doaj.org/article/ed42bbc09b42496f80578904f9f518a7
Autor:
Josep Comin Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchia, Isabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sanchez
Publikováno v:
Journal of Comparative Effectiveness Research (2023)
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation (NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study on patients with NVAF who started their treatment with apixaban or acen
Externí odkaz:
https://doaj.org/article/87a2b1a2918640ad801f9041d2d3edc9
Autor:
Fernando do Pazo-Oubiña, Bartomeu Alorda-Ladaria, Ana Gomez-Lobon, Bàrbara Boyeras-Vallespir, María Margalida Santandreu-Estelrich, Clara Martorell-Puigserver, María Gomez-Zamora, Pere Ventayol-Bosch, Olga Delgado-Sanchez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract More thermolabile drugs are becoming available, and in most cases, these medications are dispensed to ambulatory patients. However, there is no regulation once medications are dispensed to patients and little is known with regard to what hap
Externí odkaz:
https://doaj.org/article/1749a2a11700472b8a3351a1476abff0
Publikováno v:
Journal of Multidisciplinary Healthcare. 16:1037-1046
Ramón Morillo-Verdugo,1 Rosa Morillo-Lisa,2 Jaime Espolita-Suarez,3 Olga Delgado-Sanchez4 1Pharmacy Hospital Service, Hospital Valme, Ãrea de Gestión Sanitaria Sur de Sevilla, Sociedad Española de Farmacia Hospitalaria, Sevilla, Spain; 2R
Publikováno v:
Journal of Multidisciplinary Healthcare.
Ramón Morillo-Verdugo,1 Rosa Morillo-Lisa,2 Jaime Espolita-Suarez,3 Olga Delgado-Sanchez4 1Pharmacy Hospital Service, Hospital Valme, Área de Gestión Sanitaria Sur de Sevilla, Sociedad Española de Farmacia Hospitalaria, Sevilla, Spain; 2Rural Com
Autor:
Miguel G Uriol Rivera, Sheila Cabello Pelegrin, Carmen Ballester Ruiz, Bernardo López Andrade, Javier Lumbreras, Aina Obrador Mulet, Albert Perez Montaña, Mireia Ferreruela Serlavos, José Ignacio Ayestarán Rota, Joana Ferrer Balaguer, Olga Delgado Sanchez, Lucio Pallares Ferreres, Antonio Mas Bonet, María Jose Picado Valles, Rosa María Ruíz de Gopegui Valero
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206558 (2018)
BACKGROUND:Thrombotic microangiopathy (TMA) is an important complication associated with several diseases that are rare and life-threatening. TMA is common to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP is defin
Externí odkaz:
https://doaj.org/article/4b633820059247b0b2bd696a2da30583
Autor:
José Vicente Moreno-Muelas, Francisco Zaragozá, Maria Jesús Sanz Ferrando, Kevin Klein, Robin Thorpe, Olga Delgado Sanchez, Joan Albanell, Francisco J. de Abajo
Publikováno v:
Generics and Biosimilars Initiative Journal. 6:31-37
Autor:
Carmen Ballester Ruiz, B. Andrade, José Ignacio Ayestarán Rota, Sheila Cabello Pelegrin, Antonio Mas Bonet, Javier Lumbreras, Albert Pérez Montaña, Rosa María Ruíz de Gopegui Valero, Lucio Pallares Ferreres, María Jose Picado Valles, Olga Delgado Sanchez, Aina Obrador Mulet, Miguel Giovanni Uriol Rivera, Joana Maria Ferrer Balaguer, Mireia Ferreruela Serlavos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0206558 (2018)
PLoS ONE, Vol 13, Iss 11, p e0206558 (2018)
Background Thrombotic microangiopathy (TMA) is an important complication associated with several diseases that are rare and life-threatening. TMA is common to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP is defin
Autor:
Miguel Giovanni Uriol Rivera, Javier Lumbreras Fernandez, Sheila Cabello Pelegrin, Olga Delgado Sanchez, Maria del Carmen Ballester Ruiz, B. Andrade
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii137-iii137
Autor:
Uriol-Rivera, Miguel G.1,2 (AUTHOR) miguelg.uriol@ssib.es, Obrador-Mulet, Aina1,2 (AUTHOR), Juliá, Maria Rosa2,3 (AUTHOR), Daza-Cajigal, Vanessa2,3 (AUTHOR), Delgado-Sanchez, Olga2,4 (AUTHOR), Garcia Alvarez, Angel4 (AUTHOR), Gomez-Lobon, Ana4 (AUTHOR), Carrillo-Garcia, Paula5 (AUTHOR), Saus-Sarrias, Carlos5 (AUTHOR), Gómez-Cobo, Cristina2,6 (AUTHOR), Ramis-Cabrer, Daniel2 (AUTHOR), Gasco Company, Joan1,2 (AUTHOR), Molina-Infante, Javier7 (AUTHOR), Luque-Ramirez, Manuel8 (AUTHOR), Chavez, Lia Natero8 (AUTHOR)
Publikováno v:
Scientific Reports. 2/28/2024, Vol. 14 Issue 1, p1-11. 11p.